- Recent Funding
- Investors
- Goldman Sachs Alternatives
Goldman Sachs Alternatives portfolio
Goldman Sachs Alternatives has 17 portfolio companies on record at Recent Funding, with 12 investments in the last 12 months.
About this page
It led 11 of the 18 rounds it joined. Its most recent investment on record is Cyera's $400M Series B+ round in September 2026, which it led. By category, its portfolio leans toward Health and bio (5) and Fintech (4). It has co-invested with Omega Funds, Sequoia and T. Rowe Price, most often Omega Funds (3 rounds).
What Goldman Sachs Alternatives invests in
- Health and bio · 5 · 29%
- Fintech · 4 · 24%
- AI agents · 3 · 18%
- Developer tools and cloud · 3 · 18%
- Education · 3 · 18%
- Legal and compliance · 2 · 12%
- Insurance · 2 · 12%
- ZK and privacy · 1 · 6%
Goldman Sachs Alternatives recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $400M · lead | none named | ||
| Series B+ · $550M | Verified Capital, Sapphire Ventures, Evantic Capital +6 | ||
| Series B+ · $156M | Summit Partners (lead), Docusign, Wells Fargo | ||
| Series B+ · $152M · lead | Kalehua Capital, EQT Life Sciences, Droia Ventures +4 | ||
| Series B+ · $100M · lead | LG Technology Ventures, AMD Ventures, Maximus +1 | ||
| Series B+ · $150M · lead | SoftBank Investment Advisers, TLV Partners, TCV +4 | ||
| Series B+ · $60M · lead | Revolution, Citi Impact Fund, EJF Ventures | ||
| Series A · $52M | Aberdeen, Marshall Wace, Galapagos +6 |
How Goldman Sachs Alternatives invests
Goldman Sachs Alternatives portfolio companies
CCyera$400MSeries B+ · Sep 2026
HHarvey$550MSeries B+ · Sep 2026
SSocure$156MSeries B+ · Aug 2026
VVaderis Therapeutics$152MSeries B+ · Aug 2026
SSpectro Cloud$100MSeries B+ · Aug 2026
AAidoc$150MSeries B+ · Apr 2026
KKashable$60MSeries B+ · Apr 2026
TThird Arc Bio$52MSeries A · Feb 2026
RRedwood Materials$425MSeries B+ · Jan 2026
AAirNexis Therapeutics$200MSeries A · Jan 2026
NNeural Concept$100MSeries B+ · Dec 2025
FFederato$100MSeries B+ · Nov 2025
MMoEngage$60MSeries B+ · Nov 2025
SSimetrikSeries B+ · Jun 2025
BBestow$120MSeries B+ · May 2025
VVantaSeries B+ · Jul 2024
AAlphaSensebacker
| Company | Round with Goldman Sachs Alternatives | Total raised | Latest raise |
|---|---|---|---|
Legal and compliance |
Series B+ · $400M · lead | $2.7B | Sep 22, 2026 Series B+ |
AI agents |
Series B+ · $550M | $1.15B | Sep 21, 2026 Series B+ |
ZK and privacy |
Series B+ · $156M | $784.9M | Aug 27, 2026 Series B+ |
Health and bio |
Series B+ · $152M · lead | $152M | Aug 11, 2026 Series B+ |
Developer tools and cloud |
Series B+ · $100M · lead | $222.5M | Aug 1, 2026 Series B+ |
Health and bio |
Series B+ · $150M · lead | $373M | Apr 29, 2026 Series B+ |
Fintech |
Series B+ · $60M · lead | $85.6M | Apr 27, 2026 Series B+ |
Health and bio |
Series A · $52M | $217M | Feb 4, 2026 Series A |
AI infrastructure and compute |
Series B+ · $425M | $3.02B | Jul 31, 2026 round |
Health and bio |
Series A · $200M | $200M | Jan 9, 2026 Series A |
Education |
Series B+ · $100M · lead | $136.1M | Dec 18, 2025 Series B+ |
Insurance |
Series B+ · $100M · lead | $180M | Nov 18, 2025 Series B+ |
AI coding and devtools |
Series B+ · $60M · lead | $238.25M | Dec 21, 2025 Series B+ |
Fintech |
Series B+ · lead | $55M | Jun 4, 2025 Series B+ |
AI agents |
Series B+ · $120M · lead | $257.5M | May 13, 2025 Series B+ |
DEXs and AMMs |
Series B+ | $40M | Jun 24, 2026 Seed |
Data and analytics |
backer | $830M | Jun 3, 2026 round |
Most frequent co-investors
OOmega Funds3 shared rounds · last Aug 11, 2026
SSequoia2 shared rounds · last Sep 21, 2026
TT. Rowe Price2 shared rounds · last Feb 4, 2026
MMarshall Wace2 shared rounds · last Feb 4, 2026
HHillhouse Investment2 shared rounds · last Feb 4, 2026
KKleiner Perkins1 shared round · last Sep 21, 2026
WWndrCo1 shared round · last Sep 21, 2026
SSapphire Ventures1 shared round · last Sep 21, 2026
LLightspeed1 shared round · last Sep 21, 2026
VVerified Capital1 shared round · last Sep 21, 2026
GGIC1 shared round · last Sep 21, 2026
EEvantic Capital1 shared round · last Sep 21, 2026
Similar investors
KKorea Investment Partners17 companies · 7 deals in 12 mo
DDrive Capital17 companies · 6 deals in 12 mo
MMolten Ventures17 companies · 5 deals in 12 mo
PPitango VC17 companies · 3 deals in 12 mo
OOxford Science Enterprises18 companies · 11 deals in 12 mo
AAtlas Venture18 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 18 rounds on Recent Funding that name Goldman Sachs Alternatives. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Goldman Sachs Alternatives, which is a subset of its real portfolio. API: /api/v1/investors/goldman-sachs-alternatives (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy